4-(甲氧基噻吩基)-3-(取代苯甲酰基)-吡咯类化合物的合成与抗肿瘤活性研究
|
摘要
分别以2-甲氧基噻吩、3-甲氧基噻吩、3,4-二溴噻吩和取代苯乙酮为原料,经过溴甲氧基取代反应、VilsmeierHack反应、羟醛缩合和Van Leusen吡咯合成法,设计并合成了33个未见文献报道的4-取代噻吩基吡咯类化合物.其结构均经~1H NMR,~(13)C NMR及HRMS确认,同时采用噻唑蓝(MTT)法测试了目标化合物对CHO、HCT-116、MGC80-3、SGC-7901以及HUVEC细胞增殖抑制活性.结果显示,部分化合对MGC80-3细胞有较强(IC_(50)≤20μml/L)或中等(20μmol/L 33 novel 4-substituted thienyl pyrrole compounds were synthesized via replacement, Vilsmeier-Hack, aldol condensation and Van Leusen pyrrole reaction using 2-methoxythiophen, 3-methoxythiophene, 3,4-dibromothiophene and substituted acetophenone as raw materials. The structures of all target compounds were characterized by ~1H NMR, ~(13) C NMR and HRMS, meanwhile the cell proliferation inhibition efficacy was estimated against CHO, HCT-116, MGC80-3, SGC-7901 and HUVEC cell lines. The results revealed that some target compounds exhibited strong(IC_(50)≤20 μmol/L) or moderate(20μmol/L
引文
[1]Gholap,S.S.Eur.J.Med.Chem.2016,110,13.
[2]Estevez,V.;Villacampa,M.;Menendez,J.C.Chem.Soc.Rev.2010,39,4402.
[3]Ma,J.;Lu,X.;Xia,Y.;Yan,F.J.Chromatogr.Sci.2015,53,380.
[4]Lazerges,M.;Chane-Ching,K.I.;Aeiyach,S.;Chelli,S.;PeppinDonnat,B.;Billon,M.;Lombard,C.;Maurel,F.;Jouini,M.J.Solid State Electrchem.2009,13,231.
[5]Walsh,C.T.;Garneau-Tsodikova S.;Howard-Jones,A.R.Nat.Prod.Rep.2006,23,517.
[6]Battilocchio,C.;Poce,G.;Alfonso,S.Bioorg.Med.Chem.2013,21,3695.
[7]Biava,M.;Porretta,G.C.;Deidda,D.;Pompei,R.;Tafic A.;Manettic,F.Bioorg.Med.Chem.2004,12,1453.
[8]Protopopova,M.;Bogatcheva,E.;Nikonenko,B.;Hundert,S.;Einck,L.;Nacy,C.A.Med.Chem.2007,3,301.
[9]Shattat,G.F.;Abuskeika,G.M.;Al-Qirim,T.M.Lat.Am.J.Pharm.2015,34,1258.
[10]Dannhardt,G.;Kiefer,W.;Kr?mer,G.;Maehrlein,S.;Nowe U.;Fiebich,B.Eur.J.Med.Chem.2000,35,499.
[11]Teixeira,C.;Barbault,F.;Rebehmed,J.;Liu,K.;Xie,L.;Lu,H.;Jiang,S.;Fan B.;Maurel,F.Bioorg.Med.Chem.2008,16,3039.
[12]Lankheet,N.A.G.;Hillebrand,M.J.X.;Rosing H.;Schellens,J.H.M.;Beijnen,J.H.;Huitema,A.D.R.Biomed.Chromatogr.2013,27,466.
[13]Molina,A.M.;Jia,X.;Feldman,D.R.Clin.Genitourin.Cancer2013,11,297.
[14]Bailly,C.Mar.Drugs 2015,13,1105.
[15]Lan,L.;Zhan,X.-P.;Qin,W.-X.;Liu,Z.-L.;Mao,Z.-M.Heterocycles 2014,89,375.
[16]Lan,L.;Qin,W.-X.;Zhan,X.-P.;Liu,Z.-L.;Mao,Z.-M.Anti-Cancer Agents Med.Chem.2014,14,994.
[17]Li,Y.-Z.;Zhao,P.;Zhan,X.-P.;Liu,Z.-L.;Mao,Z.-M.Chin.J.Org.Chem.2015,35(1),167(in Chinese).(李衍忠,赵萍,詹晓平,刘增路,毛振民,有机化学,2015,35(1),167.)
[18]Zhan,X.-P.;Lan,L.;Zhang,Y.-K.;Chen,J.;Zhao,K.;Wang,S.;Xin,Y.-X.;Mao,Z.-M.Bull.Korean Chem.Soc.2016,37,200.
[19]Zhan,X.-P.;Lan,L.;Wang,S.Chem.Biodiversity 2016,14(2),n/a.
[20]Chen,J.;Zhang,Y.-K.;Zhan,X.-P.;Liu,Z.-L.;Mao,Z.-M.Chin.J.Org.Chem.2016,36,572(in Chinese).(陈简,张袁魁,詹晓平,刘增路,毛振民,有机化学,2016,36,572.)
[21]Chen,S.;Lu,B.Y.;Duan,X.J.Polym.Sci.Part A:Polym.Chem.2012,50,1967.
[22]Shen,P.;Liu,X.P.;Jiang,S.H.;Wang,L.;Yi,L.;Ye,D.D.;Zhao,B.;Tan,S.T.Dyes Pigm.2012,92,1042.
[23]Vilsmeier,A.;Haack,A.Chem.Ber.1927,60,119
[24]Blockhuys,F.;Hoefnagels,R.;Peten,C.;Alsenoy,C.V.;Geise,H.J.J.Mol.Struct.1999,485,87.
[25]Batista,R.M.F.;Costa,S.P.G.;Belsley,M.;Lodeiro,C.;Raposo,M.M.M.Tetrahedron 2008,64,9230.
[26]van Leusen,A.M.;Siderius,H.;Hoogenboom,B.E.;van Leusen,D.Tetrahedron Lett.1972,52,5337.
[27]Leeper,F.J.;Kelly,J.M.Org.Prep.Proced.Int.2013,45,171.
[28]Zhou,J.J;Yue,X.F.;Han,J.X.;Yang,W.Y.Chin.J.Pharm.1993,24,455.
[29]Chadwick,J.J.Chem.Soc.,Perkin Trans.1 1973,2327.
[2]Estevez,V.;Villacampa,M.;Menendez,J.C.Chem.Soc.Rev.2010,39,4402.
[3]Ma,J.;Lu,X.;Xia,Y.;Yan,F.J.Chromatogr.Sci.2015,53,380.
[4]Lazerges,M.;Chane-Ching,K.I.;Aeiyach,S.;Chelli,S.;PeppinDonnat,B.;Billon,M.;Lombard,C.;Maurel,F.;Jouini,M.J.Solid State Electrchem.2009,13,231.
[5]Walsh,C.T.;Garneau-Tsodikova S.;Howard-Jones,A.R.Nat.Prod.Rep.2006,23,517.
[6]Battilocchio,C.;Poce,G.;Alfonso,S.Bioorg.Med.Chem.2013,21,3695.
[7]Biava,M.;Porretta,G.C.;Deidda,D.;Pompei,R.;Tafic A.;Manettic,F.Bioorg.Med.Chem.2004,12,1453.
[8]Protopopova,M.;Bogatcheva,E.;Nikonenko,B.;Hundert,S.;Einck,L.;Nacy,C.A.Med.Chem.2007,3,301.
[9]Shattat,G.F.;Abuskeika,G.M.;Al-Qirim,T.M.Lat.Am.J.Pharm.2015,34,1258.
[10]Dannhardt,G.;Kiefer,W.;Kr?mer,G.;Maehrlein,S.;Nowe U.;Fiebich,B.Eur.J.Med.Chem.2000,35,499.
[11]Teixeira,C.;Barbault,F.;Rebehmed,J.;Liu,K.;Xie,L.;Lu,H.;Jiang,S.;Fan B.;Maurel,F.Bioorg.Med.Chem.2008,16,3039.
[12]Lankheet,N.A.G.;Hillebrand,M.J.X.;Rosing H.;Schellens,J.H.M.;Beijnen,J.H.;Huitema,A.D.R.Biomed.Chromatogr.2013,27,466.
[13]Molina,A.M.;Jia,X.;Feldman,D.R.Clin.Genitourin.Cancer2013,11,297.
[14]Bailly,C.Mar.Drugs 2015,13,1105.
[15]Lan,L.;Zhan,X.-P.;Qin,W.-X.;Liu,Z.-L.;Mao,Z.-M.Heterocycles 2014,89,375.
[16]Lan,L.;Qin,W.-X.;Zhan,X.-P.;Liu,Z.-L.;Mao,Z.-M.Anti-Cancer Agents Med.Chem.2014,14,994.
[17]Li,Y.-Z.;Zhao,P.;Zhan,X.-P.;Liu,Z.-L.;Mao,Z.-M.Chin.J.Org.Chem.2015,35(1),167(in Chinese).(李衍忠,赵萍,詹晓平,刘增路,毛振民,有机化学,2015,35(1),167.)
[18]Zhan,X.-P.;Lan,L.;Zhang,Y.-K.;Chen,J.;Zhao,K.;Wang,S.;Xin,Y.-X.;Mao,Z.-M.Bull.Korean Chem.Soc.2016,37,200.
[19]Zhan,X.-P.;Lan,L.;Wang,S.Chem.Biodiversity 2016,14(2),n/a.
[20]Chen,J.;Zhang,Y.-K.;Zhan,X.-P.;Liu,Z.-L.;Mao,Z.-M.Chin.J.Org.Chem.2016,36,572(in Chinese).(陈简,张袁魁,詹晓平,刘增路,毛振民,有机化学,2016,36,572.)
[21]Chen,S.;Lu,B.Y.;Duan,X.J.Polym.Sci.Part A:Polym.Chem.2012,50,1967.
[22]Shen,P.;Liu,X.P.;Jiang,S.H.;Wang,L.;Yi,L.;Ye,D.D.;Zhao,B.;Tan,S.T.Dyes Pigm.2012,92,1042.
[23]Vilsmeier,A.;Haack,A.Chem.Ber.1927,60,119
[24]Blockhuys,F.;Hoefnagels,R.;Peten,C.;Alsenoy,C.V.;Geise,H.J.J.Mol.Struct.1999,485,87.
[25]Batista,R.M.F.;Costa,S.P.G.;Belsley,M.;Lodeiro,C.;Raposo,M.M.M.Tetrahedron 2008,64,9230.
[26]van Leusen,A.M.;Siderius,H.;Hoogenboom,B.E.;van Leusen,D.Tetrahedron Lett.1972,52,5337.
[27]Leeper,F.J.;Kelly,J.M.Org.Prep.Proced.Int.2013,45,171.
[28]Zhou,J.J;Yue,X.F.;Han,J.X.;Yang,W.Y.Chin.J.Pharm.1993,24,455.
[29]Chadwick,J.J.Chem.Soc.,Perkin Trans.1 1973,2327.